tiprankstipranks
Alphamab Oncology’s Drug Shows Promise in Clinical Studies
Company Announcements

Alphamab Oncology’s Drug Shows Promise in Clinical Studies

Alphamab Oncology (HK:9966) has released an update.

Don't Miss Our Christmas Offers:

Alphamab Oncology has announced at the ESMO Congress 2024 that their experimental drug JSKN003 shows promise in treating patients with advanced solid tumors, particularly those heavily pretreated for PROC (platinum-resistant ovarian cancer). The medication, which targets HER2, has been associated with significant tumor shrinkage and presented a favorable safety profile, suggesting further clinical evaluation is warranted.

For further insights into HK:9966 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App